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Testicular Toxicity Produced by Ethylene
Glycol Monomethyl and Monoethyl Ethers
in the Rat
by Paul M. D. Foster,*t Dianne M. Creasy,* John R. Foster*t
and Tim J. B. Gray*
Ethylene glycol monomethyl ether (EGME) and ethylene glycol monoethyl ether (EGEE) were
administered orally to young male rats at doses varying from 50 to 500 mg/kg/day and 250 to 1000 mg/kg/day
for EGME and EGEE, respectively, for 11 days. At sequential times animals were killed and testicular
histology examined. The initial and major site ofdamage following EGME treatment was restricted to the
primary spermatocytes undergoing postzygotene meiotic maturation and division. EGEE produced
damage ofan identical nature, but a largerdose was required to elicit equivalent severity (500 mg EGEE/kg
being approximately equivalent to 100 mg EGME/kg). Additionally, within the spermatocyte population,
differential sensitivity was observed depending on the precise stage ofmeiotic maturation: dividing (stage
XIV) and early pachytene (stages I-II) > late pachytene (stages VIII-XIII) > mid-pachytene (stages
III-VII). Equivalent doses ofmethoxyacetic acid (MAA) andethoxyacetic acid (EAA) gave injury similarto
the corresponding glycol ether.
When animals were pretreated with inhibitors of alcohol metabolism followed by a testicular toxic dose
of EGME (500 mg/kg), an inhibitor of alcohol dehydrogenase (pyrazole) offered complete protection.
Pretreatment with the aldehyde dehydrogenase inhibitors disulfiram or pargyline did not ameliorate
the testicular toxicity of EGME. In mixed cultures of Sertoli-germ cells, MAA and not EGME produced
effects on spermatocytes analogous to that seen in vivo, at concentrations approximately equivalent
to steady-state plasma levels after a single oral dose of EGME (500 mg/kg). It would seem likely that
a metabolite (MAA or possibly methoxyacetaldehyde) and not EGME is responsible for the production
of testicular damage.
Introduction
The ability of ethylene glycol mono-n-alkyl ethers to
produce testicular damage has been known for some
time. Wiley et al. (1) first demonstrated the testicular
effects ofethylene glycol monomethyl ether (EGME) in
rabbits in 1938. Stenger et al. (2) have shown that the
monoethyl derivative (EGEE) can also induce testicular
damage in dogs and rats. More recently, Nagano and
others (3), using a variety of ethylene glycol monoalkyl
ethers in studies with orally treated mice, have shown
EGME, ethylene glycol monomethyl ether acetate
(EGMEA) and EGEE to be the most potent of the
series examined in producing adverse testicular effects.
EGME has also been shown to produce a decrease in
testicular weight in the rat and mouse following inhala-
tion exposure for 2 weeks at 1000 ppm (4).
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The objectives ofthe studies detailed here were, first,
to establish the dose-response relationship between
testicular damage and oral ingestion ofeither EGME or
EGEE; second, to observe the temporal development of
the testicular lesion and deduce the target cell type
involved, and, third, to ascertain whether the parent
compounds and/or metabolites were responsible for the
observed testicular damage.
Methods
Dose-Response, Time-Course Study
Animals were randomly assigned to nine treatment
groups containing 36 animals per group. Groups 2 to 5
received EGME by oral gavage at dose levels of50, 100,
250 or 500 mg/kg/day. Groups 7 to 9 were administered
EGEE by the same route at levels of 250, 500 or 1000
mg/kg/day. Groups 1 and 6 were given an equivalent
volume ofthe water vehicle (5mL/kg/day) and served as
control groups for EGME and EGEE, respectively.FOSTER ET AL.
Six animals from each group were killed, by cervical
dislocation, 6 and 24 hr after a single dose. Further
groups received repeated daily doses and were killed
after 2, 4, 7 and 11 days. At postmortem, the testes,
seminal vesicles, prostate and liver were excised and
weighed and testes, epididymides and liver fixed for
examination bylight orelectron microscopy (see below).
Recovery Study
Groups ofanimals received 500 mg EGME/kg/day by
oral gavage for 4 days, control animals receiving an
equivalent volume of water vehicle. After cessation of
treatment, animals (six per group) were killed from
both the treated and control groups at 0, 2, 4 or 8
weeks. Tissues taken for examination were as described
above.
Histology
In most experiments, one testis, the epididymides
and a sample ofliver were fixed in Bouin's fluid for light
microscopy. The other testis and a sample ofliver were
diced and fixed in 4% formaldehyde plus 1% glutaralde-
hyde in 0.1 M phosphate buffer, pH 7.29 (5). In the
recovery study, both testes and epididymides were fixed
in Bouin's fluid.
For examination by light microscopy, tissues were
fixed for24 hr and processed into paraffin wax. Sections
were stained with hematoxylin and eosin and with
periodic acid-Schiff technique for the demonstration of
the spermatid acrosome (6). Definition of the stages of
spermatogenesis was based on that used by Leblond
and Clermont (7).
For examination bytransmission electron microscopy,
the tissue was stored in fixative at 4°C and processed
only if selected by prior examination of the sample
taken for light microscopy. Samples were post-fixed in
1% osmium tetroxide, dehydrated in graded ethanols
and embedded in Epon/Araldite; 90 mm sections were
cut and stained with uranyl acetate and lead hydroxide.
Metabolism and Tissue Distribution of
a Single Oral Dose of [14C] EGME
Twelve rats were treated with [14C]methoxy-labeled
EGME (500 mg/kg; 25 uCi/kg), dissolved in water by
oral intubation. Urine, feces and expired air were
monitored for [14C] content over a48 hrperiod. Animals
were killed after 24 and 48 hr (six animals per time) and
tissue radioactivity estimated by sample oxidation by
using a Packard Model 306 oxidizer.
Analysis of Urinary Metabolites
Metabolites were analyzed by using a Varian Vista
LC 5040 HPLC, fitted with a 300 mm x 5 mm internal
diameter column containing Varian Micropak MCH-10
ODS and a 50 mm x 4.6 mm internal diameter column
packed with CO:PELL:ODS. Samples (approximately
20,000 dpm) were applied to the column and eluted at 2
mL/minwith alinearmethanol:water:1% aqueous sulfu-
ric acid gradient. The effluent was monitored by UV
absorbence at 200 nm and by liquid scintillation count-
ing ofcollected 0.3 min fractions. Peaks were compared
with those of known unlabeled standards.
Aliquots ofcollected feces werehomogenized inwater
and homogenate examined for total [4C] by sample
oxidation. Samples were also filtered and examined by
the HPLC method described above. Expired air from
the metabolism chambers was passed through satu-
rated barium hydroxide solution and a water trap for
collection of[14C]C02 as precipitated carbonate. Follow-
ing filtration of the barium hydroxide solution, the
filtrate was examined for metabolites by HPLC and
radioactivity present in the precipitate by sample
oxidation, followed by liquid scintillation counting.
Experiments with 2-Methoxy- and
2-Ethoxyacetic Acids in Vivo
After suitable doses and periods of exposure had
been established for the parent glycol ethers, further
groups of animals were treated with the corresponding
acetic acids. One group received MAA for 4 days
(equimolar to 500 mg/kg/day EGME) and a second EAA
11 days (equimolar to 500 mg/kg/day EGEE), controls
received an equivalent volume of water (5 mg/kg/day).
Upon sacrifice tissues taken were as described above.
Experiments with Inhibitors
of Alcohol Metabolism
In each experiment 24 rats were randomly assigned
to four groups. Groups 2 and 4 were treated with
inhibitorand groups 1 and 3 received an equal volume of
the appropriate control vehicle. One hourlater, groups 3
and 4 received EGME (500 mg/kg) by oral intubation
and groups 1 and 2 an equivalent volume of water (5
mL/kg). Pyrazole was administered IP at a dose level of
400 mg/kg dissolved in water, disulfiram IP at 100
mg/kg in corn oil and pargyline IP 100 mg/kg in water.
These concentrations were known to be effective in
inhibiting hepatic alcohol (pyrazole) and aldehyde
(disulfiram and pargyline) dehydrogenases.
Animals were killed by cervical dislocation 24 hr after
the last dose and the testes and epididymides excised,
weighed and fixed in Bouin's fluid. Transverse sections
of paraffin wax-embedded material were prepared and
stained with hematoxylin and eosin for assessment of
testicular damage by light microscopy.
In Vitro Effects of EGME and MAA
Mixed cultures of Sertoli and germ cells from testes
of 4-week-old rats were prepared by a modification of
the method of Steinberger et al. (8) described in detail
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elsewhere (9). Testes were decapsulated, coarsely
chopped and dissociated into individual tubules by
incubation with 0.25% (w/v) trypsin. After washing in
Hank's balanced salt solution, they were further incu-
bated with 0.1% (w/v) collagenase until the tissue was
reduced to small aggregates of Sertoli and germ cells.
These were then cultured in 50 mm dishes containing
glass coverslips. The culture medium comprised Eagle's
minimal essential medium with 10% (v/v) fetal calf
serum with the addition of4 mM L-glutamine, 0.1 mM
nonessential amino acids, 100 U/mL penicillin and 100
,ig/mL streptomycin. After 24 hr incubation in a
humidified atmosphere of 5% C02:95% air, the culture
medium was replaced with serum-free medium contain-
ing appropriate concentrations of EGME (0-50 mM) or
MAA (0-10 mM). Coverslips were removed at intervals
and cells fixed in Bouin's fluid and stained with hema-
toxylin and eosin. The culture medium was replaced
with appropriately treated medium every 24 hr.
Results
Dose-Response, Time-Course Study
The first significant decrease in relative testicular
weight in the EGME group was evident at day 2 after
500 mg/kg/day (Fig. 1). Thereafter, decreases inrelative
testis weight became more pronounced with increasing
dose and were statistically significant in the 250
EGME
mg/kg/day group by 7 days. The liver showed decreased
relative weight differing from control values in the 100,
250 and 500 mg/EGME/kg groups after 24 hr. Liver
EGME
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FIGURE 2. Effect of period of EGME exposure on relative liver
weight. Numbers in columns refer to dose level (mg/kg/day).
Significance: *p < 0.05; **p < 0.01 compared to corresponding
control (Dunnett's test). Vertical bars indicate SE.
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FIGURE 1. Effect of period of EGME exposure on relative testis
weight. Numbers in columns refer to dose level (mg/kg/day).
Significance: *p < 0.05; **p < 0.01 compared to corresponding
control (Dunnett's test). Vertical bars indicate SE.
FIGURE 3. Effect of period of EGEE exposure on relative testis
weight. Numbers in columns refer to dose level (mg/kg/day).
Significance: *p < 0.05; **p < 0.01 compared to corresponding
control (Dunnett's test). Vertical bars indicate SE.
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weights also differed in the 250 and 500 mg/kg/day
groups on days 4 and 7 but returned to control levels
by day 11 (Fig. 2).
No evidence of a significant decrease in relative testis
weight was obtained until day 11 in the animals treated
with EGEE when decreases were recorded in the 500
and 1000 mg/kg/day groups (Fig. 3). Isolated occur-
rences of statistically significant differences in relative
liver weight were also noted (data not shown). In
general, the 500 mg/kg/day group showed greater
changes in relative organ weight than the 1000mg/
kg/day group.
Recovery Study
Treatment with EGME for 4 days at a dose level of
500 mg/kg/day resulted in marked decreases in liver and
testis relative weights (as described above). On allowing
the animals to recover after treatment (Table 1), liver
weights had returned to normal at the first time point (2
weeks). Testes weights, however, did not return to
controlvaluesuntil8weeksaftercessation oftreatment.
Histology
EGME Treatment. Dosing with 50 mg/kg/day pro-
duced no testicular abnormalities, but 100, 250 and 500
mg/kg/day resulted in degeneration of pachytene sper-
matocytes evident 24 hr after a single dose. The
proportion ofthe spermatocyte population affected was
directly related to dose. Continued dosing resulted in
progressive depletion ofspermatocytes and in amatura-
tiondepletion ofthe early spermatid population. Degen-
erative changes consisted ofgeneral cellular shrinkage,
increasedcytoplasmiceosinophilia and nuclearpyknosis.
These changes were restricted tothe secondary sperma-
tocytes and to pachytene, diplotene, diakinetic and
dividing stages of primary spermatocyte development;
the preleptotene, leptotene and zygotene spermato-
cytes remained unaffected except at the highest dose
level. These effects on spermatocyte maturation and
division appeared stage-dependent. The most sensitive
cells being spermatocytes undergoing division or in
early pachytene (stages XIV and I-II, respectively),
spermatocytes in late pachytene (stages X-XIII) less so
and those in mid-pachytene (stages III-IX) being least
sensitive (Figs. 4-6).
After 11 days of dosing with 250 and 500 mg/kg/day,
spermatid and late spermatocyte populations were
absent. Zygotene spermatocytes showed a marked in-
crease in number indicating maturation arrest. At all
dose levels and times the spermatogonia, pre-leptotene
spermatocytes, Leydig and Sertoli cells appeared
normal.
Ultrastructural examination of testes 24 hr after a
single dose showed a proportion of the spermatocyte
population in advanced stages of necrosis. An earlier
time point (16 hr) was required to show early signs of
degeneration; these were again restricted to sper-
matocytes, the most prominent of the changes was
found to be mitochondrial swelling and disruption (Fig.
7), cytoplasmic vacuolation and early condensation of
nuclear chromatin. The cytology ofthe other germ cells
and of the Leydig and Sertoli cells appeared normal.
EGME Recovery. The group of animals killed at
zero time recovery, i.e., after four daily doses of 500
mg/kg, showed the same distribution and extent of
damage as found in the equivalent time kill in the
dose-response study described above. Two weeks after
cessation of treatment, maturation depletion had pro-
gressed to involve all middle and late stage spermatids.
Occasional tubules contained newly formed Golgi-phase
spermatids, but most contained either early or late
pachytene spermatocytes as the most mature cell
present. In control animals (of equivalent age) sper-
matozoal production had begun, evidenced by the pres-
ence of sperm in the epididymides. At 4 weeks, recov-
ery had progressed and maturation phase spermatids
were frequently seen. By 8 weeks full spermatogenesis
was present in the majority of tubules from all animals
and all showed epididymal spermatozoa, although quan-
titatively less than in the age-equivalent controls. Most
animals also contained a proportion (<10%) of tubules
which appeared totally atrophic, composed only of
Sertoli cells.
EGEE Treatment. Dosing of animals with 500 or
1000 mg/kg/day produced spermatocyte degeneration of
a severity similar to that seen with EGME administered
at 100 mg/kg/day. Although the degree ofspermatocyte
Table 1. Relative organ weights of male rats exposed to EGME and allowed to recover from treatment for 2, 4 and 8 weeks.
Relative organ wt, g/100 g body weighta
0 Recovery 2 weeks Recovery 4 weeks Recovery 8 weeks
Testes
Controlb 0.985 ± 0.028 0.473 ± 0.017 0.448 ± 0.010 0.690 ± 0.038
EGME 0.752 ± 0.031* 0.221 ± 0.011* 0.255 ± 0.019* 0.643 ± 0.037
Liver
Control 4.821 ± 0.115 4.800 ± 0.156 4.368 ± 0.171 3.675 ± 0.095
EGME 3.850 ± 0.061 4.760 ± 0.067 4.062 ± 0.084 3.651 ± 0.069
aValues are means ± SE for six animals.
bAnimals received 500 mg/kg/day EGME for 4 days and were then allowed to recover. Controls received an equivalent volume of the water
vehicle (5 mL/kg/day).
*Significant at p < 0.001, compared to corresponding control (Student's t-test).
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FIGURE 4. Seminiferous tubules from control rat. Thbule inearly stage ofspermatogenesis (I-III) on the left and inmid-stage (VIII-IX) on the
right. Hematoxylin and eosin; x290.
FIGURE 5. Seminiferous tubules from rattreated 24 hrpreviouslywith250mgEGME/kg. Stageand orientation oftubules as inFig. 4. Notethe
early pachytene spermatocyte population shows nuclear pyknosis (arrowed) whereas mid-pachytene spermatocytes are unaffected.
Hematoxylin and eosin; x290.
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FIGURE 6. Seminiferous tubules from rattreated 24 hrpreviouslywith250mgEGME/kg. Tubules areinstage XIV (left) and stage XI (right) of
spermatogenesis. Many dividing spermatocytes show nuclear pyknosis and cytoplasmic eosinophilia (arrowed), while late pachytene
spermatocytes in the stage XI tubule are unaffected. Hematoxylin and eosin; x290.
FIGURE 7. Electron micrograph of a seminiferous tubule from a rat treated 16 hr previously with 500 mg EGME/kg. Note cytoplasmic
vacuolation and mitochondrial disruption in the spermatocyte surrounded by a Sertoli cell of normal appearance. x 5850.
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degeneration was broadly similar for both of the above
treatmentgroups after 11 days oftreatmentthe onset of
degeneration was more pronounced with the lower dose
level. The target cell types were found to be as
described for EGME. Sertoli and Leydig cells,
spermatogonia, prepachytene spermatocytes and sper-
matids were unaffected apart from partial maturation
depletion of early stage spermatids.
LiverHistology. None ofthe compounds examined
produced any histological or ultrastructural abnormali-
ties at any dosage.
Tissue Distribution and Urinary Metabolites
Following aSingle Oral Dose of[14C]EGME
The distribution of radioactivity in urine, feces,
exhaled air and tissues is described in Table 2. Within
24 hr, approximately 60% of the dose was recovered in
urine, with a further 11% in the 24 to 48 hr period.
Feces contained 1% of the dose in the first 24 hr,
predominantly astheparentcompound. Likewise, radio-
activity recovered in expired air was also in the form of
EGME. There was notestis-specific uptake oraccumula-
tion ofradioactivity (approximately 0.15% ofdose in 24
hr), label being detected in all the tissues selected for
examination. The urinary metabolic profile for EGME
is shown in Figure 8. The major metabolite found in
urine was MAA (73.1%); EGME (14.8%) was also
detected together with a third peak (8.1%) that did not
chromatograph with any of the standards used.
Tble 2. Distribution of ["4C]EGME after a single oral dose.a
Time after dose, hr. % of administered doseb
Urine 0-24C 58.5 ± 2.3
Feces 1.0 ± 0.2
Exhaled 2.3 ± 0.3
Urine 24-48d 11.5 ± 0.8
Feces 0.5 ± 0.1
Exhaled 0.4 ± 0.2
Tissues 12.5 ± 0.9
Total 86.7
(range 81.7-94.5)
aAnimals received a single oral dose of [14C]EGME (500 mg/kg,
25 ,uCi/kg) dissolved in water.
bValues are means ± SE.
Cn= 12.
dn= 6.
Table 3. Effect of 2-methoxyacetic acid (MAA) on the relative
organ weights of testes and liver.a
Relative organ weight, g/100 g body weightb
Tissue Control MAA
Testes 0.985 ± 0.028 0.773 ± 0.022*
Liver 4.821 ± 0.115 4.237 ± 0.104'
aAnimals received MAA by oral gavage at a dose level of 592
m/kg/day for 4 days or an equivalent volume ofwater (5 mL/kg/day).
Values are means ± SE for six animals.
*p < 0.001 compared to control (Student's t-test).
tp < 0.01 compared to control (Student's t-test).
In Vivo Effects of MAA and EAA
Animals treated with 2-methoxyacetic acid exhibited
similar changes in relative testis and liver weight as
obtained with the corresponding glycol ether given at
an equivalent dose for the same period (Table 3). The
MAA
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FIGURE 8. Typical HPLC separation ofradiolabelled metabolites of
[14C]EGME. A 30,uL portion of urine (containing approximately
20,000 dpm) was injected into the column and eluted (2 mL/min)
with a ternary solvent system comprising (solvent A) water;
(solvent B) methanol; (solvent C) 1% v/v aqueous sulfuric acid
(held at 7% throughout). Figures represent the percent loading
recovered in the peaks indicated; tR
= retention time.
Table 4. Effect of aldehyde and alcohol dehydrogenase inhibitors
on the testicular toxicity of EGME and MAA.a
Agent Testicular damageb
EGME + + +
MAA + + +
EGME + pyrazole (400 mg/kg IP) NAD
EGME + disulfiram (100 mg/kg IP) + + +
MAA + disulfiram (100 mg/kg IP) + + +
MAA + pargyline (100 mg/kg IP) + + +
aInhibitors were given 1 hr prior to treatment with either EGME
(500 mg/kg PO) or an equimolar dose of MAA (592 mg/kg PO).
bTesticular score (evaluated 24 hr after last dose): NAD = no
abnormality detected; + + + = spermatocytes in majority (> 75%)
of tubules exhibiting degeneration.
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(a)
(b)
FIGURE 9. Sertoli germ cellculture24hrafterexposure to (a) control medium or(b) 5mM MAA. Noteloss ofpachytene spermatocytes (PS). SC
refers to Sertoli cells, Sg = spermatogonia, LS = leptotene/zygotene spermatocytes. Hematoxylin and eosin; x 528.
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severity and nature of the testicular lesion was essen-
tially similar to that obtained for EGME. Animals
treated with EAA for 11 days showed a similar pattern
of spermatocyte degeneration and depletion to that of
the corresponding glycol ether.
Effects of Metabolic Inhibitors
Pyrazole, an inhibitor of alcohol dehydrogenase was
the only inhibitor used which exhibited protective
effects against EGME toxicity (Table 4). Inhibition of
aldehyde dehydrogenase activity by disulfiram pretreat-
ment had no effect on the degree of testicular damage
obtained with EGME, but a similar result was also
obtained when MAA was used in conjunction with
disulfiram or a further aldehyde dehydrogenase inhibi-
tor (pargyline). None of the treatments produced any
significant changes in testis weight, and none of the
inhibitors produced any change in testis histology when
used alone.
In Vitro Effects of EGME and MAA
Treatment ofSertoli-germ cell cultures at doses up to
50 mM EGME produced no adverse effects. However,
MAA treatment produced dose-related changes consist-
ing ofinitial degeneration and subsequent loss from the
culture ofthe spermatocyte populations. Ataconcentra-
tion of5 mM these effects were largely restricted to the
pachytene spermatocytes (Fig. 9), but at 10 mM earlier
stages were also affected.
Discussion
Following oral administration of EGME, a rapid
decrease in testis weight associated with testicular cell
damage was observed. The degree ofdegeneration was
related to both the dose administered and the period of
exposure to the compound.
Within 24 hrofasingle dose, damage was observed in
the postzygotene spermatocyte population. The sever-
ity of this was stage-dependent, with early pachytene
and dividing spermatocytes being most sensitive and
mid-pachytene least. Prolonged dosing resulted in con-
tinued spermatocyte degeneration as well as matura-
tion depletion of the spermatid population, leaving
tubules containingonly Sertoli cells, spermatogonia and
preleptotene spermatocytes. Although zygotene sper-
matocytes showed slight degeneration with prolonged
exposure to high doses, maturation arrest was evident
by the increased numbers of cells present. Arrest of
spermatocytes at this stage indicated a failure of the
cells to accomplish successful transition from zygotene
to pachytene. At the ultrastructural level the mitochon-
dria of the spermatocytes showed early evidence of
disruption.
Cessation of treatment indicated that the testicular
lesion was reversible in the large majority of tubules.
Testis weights returned to control values and the
majority of tubules regained full spermatogenesis and
spermatozoal production within one full spermatogenic
maturation cycle (7-8 weeks in the rat). The presence of
a small proportion oftotally atrophic tubules indicated a
loss of spermatogonia, although spermatagonia, when
present, appeared morphologically normal, suggesting
that they may not be totally resistant at the highest
doses and that prolonged treatment might prevent total
recovery.
Animals treated with EGEE showed a similar type of
damage to that described for EGME, although higher
doses were required to produce damage of equivalent
severity. Differences in testicular weight and the de-
layed onset of degeneration and depletion seen after
1000 mg/kg/day compared to 500 mg/kg/day would
suggest saturation ofsome metabolic process or degree
of absorption.
The present results indicate that a single oral dose
of EGME is predominantly excreted in the urine
(approximately 70% in the first 48 hr) in the form of
MAA, with no specific uptake or accumulation of
radioactivity in the testis. The data obtained were
similar to those recently presented by Miller et al. (10),
although we could show no evidence of14CO2 evolution,
only parent compound being detected in expired air.
This was almost certainly due to the employment of
[14C]methoxy-labeled EGME in our study, the ether
bond being more resistant to metabolic attack and
therefore not resulting in the excretion of [14C]CO2.
EGEE has also been shown to be metabolized to its
corresponding acetic acid derivative and in addition
N-ethyoxyacetylglycine (11). It is possible that the
unknown peak obtained in our HPLC analysis of urine
from EGME-treated animals is a glycine conjugate of
methoxyacetic acid. Further chemical analysis is being
carried out to confirm this hypothesis.
In vivo experiments with both MAA and EAA
confirmed the decrease in testis weight reported by
Miller et al. (12) for MAA and additionally showed
identical testicular lesions for the metabolites as were
encountered with the parent glycol ethers. Experi-
ments with metabolic inhibitors showed that alcohol
dehydrogenase is an important activating step in the
production of EGME testicular toxicity. Inhibition of
this enzyme with pyrazole (13) resulted in complete
protection. Our experiments have also shown reason-
able activity of alcohol dehydrogenase in the testis
compared to liver using EGME as substrate (data not
shown).
The lack of protection exhibited in EGME-dosed
animals pretreated with the aldehyde dehydrogenase
inhibitor-disulfiram (14) would suggest that methoxy-
acetaldehyde may be a toxic species (Fig. 10), aliphatic
aldehydes being known to possess profound effects on
cell division (15). The possibility existed that the
adverse testiculareffectsproducedby MAA were due to
its conversion by aldehyde dehydrogenase to methoxy-
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acetaldehyde. However, treatment with either disul-
firam or pargylene, an alternative aldehyde dehydroge-
nase inhibitor (16), prior to dosing with MAA showed
no protective effects on testicular damage. Alterna-
tive possible explanations for MAA activity are that
methoxyacetaldehyde is converted to MAA by an en-
zyme other than aldehyde dehydrogenase (aldehyde
oxidase for example) or that concentrations ofinhibitor
were insufficient to produce inhibition ofactivity in the
testis and experiments are in progress to test these
hypotheses.
Results from the testicular cell culture experiments
would suggest that EGME per se is not responsible for
testicular damage. MAA at concentrations approxi-
mately equivalent to steady-state plasma levels follow-
ing 500 mg EGME/kg PO produced analogous effects to
that seen in vivo by depleting spermatocyte numbers.
Previous studies have shown that EGME can produce
marked effects on the bone marrow and hemopoietic
systems (3,4). Miller et al. (4) have also demonstrated
CH -0-CH -CH -OH 3 2 2
EGME; 2 methoxyewaol
alcohol dhdoga
NAD/H
(pyreazolske b
#0 CH3-0-CH2 NH
al hyd dehychoganase
NAD/H
CH 0CH C OH
mwhoxyacetlc acid
Vglyckie
conthrat.
FIGURE 10. Metabolism of EGME in the rat.
the lack ofeffect ofEGME on intestinal epithelium and
follicular cells ofthe ovary, ruling out cell turnover rates
as a factor in the target organ specificity of EGME.
The results presented above have shown that EGME
and the other compounds studied affect primarily the
meiotic cells ofthe testis while cells undergoing mitotic
division appear spared, lending support to the notion
that the testicular and bone marrow effects consequent
to EGME treatment occur via different mechanisms. In
addition MAA, methoxyacetaldehyde or possibly some
further testicular metabolites are the likely toxic spe-
cies responsible for testicular damage produced by
EGME. The precise biochemical lesion affectingmeiosis
in the spermatocytes awaits identification.
This work forms part of a research project sponsored by the U.K.
Ministry ofAgriculture, Fisheries and Food, to whom our thanks are
due. The results of the research are the property of the Ministry of
Agriculture, Fisheries and Food and are Crown copyright. The expert
technical assistance of Miss L. V Thomas and Mr. M. W Cook is
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